Frank D'Amelio and Ian Read, respectively the CFO and the head of biopharmaceuticals at Pfizer, will each receive about a million dollar bonus, according to the Wall Street Journal Health Blog. They showed, according to the board's compensation committee, "devoted extraordinary efforts and made extraordinary contributions" to the Pfizer-Wyeth merger. The Health Blog notes that Pfizer plans to eliminate 20,000 jobs due to the merger.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Even when given the option, not too many authors choose double-blinded peer-review for their manuscripts, ScienceInsider reports.

In PNAS this week: transcriptional read-through in stressed cells, genome stability role for the epigenetic regulator CTCF, and more.

The Save the Redwoods League is teaming with researchers to sequence the genomes of the coast redwood and giant sequoia.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.